SCHEMBL19133019

SCHEMBL19133019

CC(C(C#N)C#N)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10897289 0.67
SCHEMBL8570920 0.67 TSHR (0.64) TSHR
Water SCHEMBL11043959 0.67 TSHR (0.44) TSHR
SCHEMBL109553 0.67
SCHEMBL6023550 0.67 KDM4E (0.35)
SCHEMBL2193129 0.65
SCHEMBL27343391 0.65 TSHR (0.50) TSHR
Trimethylammonium SCHEMBL9462043 0.65
SCHEMBL30084769 0.63 KDM4E (0.33)
Hydrochloric Acid SCHEMBL28564370 0.63 KDM4E (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9707210-B2 Methods of treating muscular dystrophy BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2017-07-18 US disclosed